Gabelli To Host 8th Annual Healthcare Symposium

What happened

Gabelli is hosting its 8th Annual Healthcare Symposium with Columbia Business School on Friday, November 13, 2026, at the Paley Center in New York. The event brings together healthcare companies and organizations to discuss industry trends, business fundamentals, and topics including oncology innovation, drug access in the specialty and GLP-1 era, and artificial intelligence in care delivery.

Confirmed

Global impact / market context

The agenda points to oncology, GLP-1 drug access, and artificial intelligence in care as areas where company spending, pricing, and reimbursement decisions are evolving. Investors holding healthcare stocks named in the program, such as AstraZeneca, Legend Biotech, Gilead, and Eli Lilly, may hear management views on competitive positioning and treatment adoption.

Analyst inference

Healthcare companies are balancing costly drug development against payer pressure and access rules, so symposium panels on specialty and GLP-1 access may highlight how revenue and costs shift across drugmakers, distributors, and care providers. The format is a company-hosted event, not new financial disclosure, so remarks are largely forward-looking opinion.

Analyst inference

What to watch

1. The program includes a session titled Cancer's Breakthrough Year: Can Care Keep Pace, moderated by Gabelli's Rebecca Stern, with speakers from Northwell Cancer Institute, Legend Biotech, Kite, and AstraZeneca. Confirmed
2. Listen for company comments on how oncology treatment capacity, manufacturing, and reimbursement may affect drug launch timelines and capital spending, since those details could inform expectations for named companies. Proposed
3. Watch whether GLP-1 access discussion signals pricing pressure or expanded coverage for obesity and diabetes drugs, which could affect revenue forecasts for Eli Lilly and costs for distributors and care providers. Analyst inference

Evidence

• globenewswire.com